Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: A 4-year prospective study in IDDM patients

Diabetologia

Volumn 41, Issue 4, 1998, Pages 443-451

  Ziegler, D ^a   Weise, F ^a   Langen, K J ^b   Piolot, R ^a   Boy, C ^a   Hubinger A ^a   Muller Gartner H W ^a,b   Gries, F A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Autonomic function tests; Diabetic cardiovascular autonomic neuropathy; Glycaemic control; MIBG scintigraphy; Sympathetic denervation

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGED; ARTICLE; AUTONOMIC INNERVATION; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCINTIGRAPHY; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PERIPHERAL NERVES; RADIOPHARMACEUTICALS; REFERENCE VALUES; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 0031943166     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050928     Document Type: Article

References (70)

1. Neil HAW, Thompson AV, John S, McCarthy ST, Mann JI (1989) Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 6: 20-24
2. Ziegler D, Gries FA, Mühlen H et al. (1993) Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diab Metab 19: 143-151
3. The EURODIAB IDDM Complications Study Group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285
4. Ziegler D (1994) Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis, and treatment. Diabetes/Metab Rev 10: 339-383
5. Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF (1991) Autonomic neuropathy, OT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 34: 182-185
6. Sundkvist G, Lilja B (1993) Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 16: 773-779
7. Töyry JP, Niskanen LK, Länsimies EA, Partanen KPL, Uusitupa MIJ (1996) Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 27: 1316-1318
8. Ziegler D, Mayer P, Mühlen H, Gries FA (1991) The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 822-829
9. Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MIJ (1996) Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 45: 308-315
10. Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8: 491-498
11. Watkins PJ (1990) Natural history of the diabetic neuropathies. Q J Med 77: 1209-1218
12. Sisson JC, Wieland DM, Mangner TJ, Tobes MC, Jacques S (1987) Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 28: 1620-1624
13. Sisson JC, Shapiro L, Meyers L et al. (1987) Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28: 1625-1636
14. 123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 44: 543-549
15. Schnell O, Kirsch C-M, Stemplinger J, Haslbeck M, Standl E (1995) Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38: 1345-1352
16. Schnell O, Muhr D, Dresel S et al. (1996) Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients. Diabetologia 39: 970-975
17. Langen K-J, Ziegler D, Weise F et al. (1997) Evaluation of QT interval length. QT dispersion, and myocardial metaiodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci 93: 325-333
18. Hattori N, Tamaki N, Hayashi T et al. (1996) Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 37: 1985-1990
19. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MIJ (1996) Demonstration of regional sympathetic denervation of the heart in diabetes. Diabetes Care 19: 1083-1090
20. Shimabukuro M, Chibana T, Yoshida H, Nagamine F, Komiya I, Takasu N (1996) Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy. Am J Cardiol 78: 1057-1059
21. 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med 13: 266-272
22. Freeman MR, Newman D, Dorian P, Barr A, Langer A (1997) Relation of direct assessment of cardiac autonomic function with metaiodobenzylguanidine imaging to heart rate variability in diabetes mellitus. Am J Cardiol 80: 247-250
23. 123I]metaiodobenzylguanidine. Diabetes 41: 1069-1075
24. 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Clin Auton Res 6: 163-169
25. Langer A, Freeman MR, Josse RG, Armstrong PW (1995) Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25: 610-618
26. Wei K, Dorian P, Newman D, Langer A (1995) Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 26: 859-863
27. Kim SJ, Lee JD, Ryu YH et al. (1996) Evaluation of cardiacsympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 23: 401-406
28. Claus D, Feistel H, Brunhölzl C, Platsch G, Neundörfer B, Wolf F (1994) Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography. Clin Auton Res 4: 117-123
29. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M (1996) Evaluating of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 37: 712-717
30. Koistinen MJ, Airaksinen KEJ, Iluikiri HV et al. (1996) No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease. Diabetes Care 19: 231-235
31. Mustonen J, Mätysaari M, Kuikka J, Vanninen E, Vainio P, Länsimies E, Uusitupa M (1992) Decreased myocardial 123I-metaiodobenzylguanidine uptake is associated with disturbed left ventricular diastolic filling in diabetes. Am Heart J 123: 804-805
32. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45: 801-805
33. Schnell O, Muhr D, Dresel S, Weiss M, Haslbeck M, Standl E (1997) Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up. Diabet Med 14: 57-62
34. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
35. European IDDM Policy Group 1993 (1993) Consensus guidelines for the management of insulin-dependent (type 1) diabetes. Diabet Med 10: 990-1005
36. Ziegler D, Laux G, Dannehl K et al. (1992) Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 9: 166-175
37. Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA (1992) Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis. vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 9: 806-814
38. Bazett HC (1920) An analysis of time-relations of electrocardiograms. Heart 7: 353-370
39. Glancy JM, Garratt CJ, Woods KL, De Bono DP (1995) QT dispersion and mortality after myocardial infarction. Lancet 345: 945-948
40. Henderson EB, Kahn JK, Corbett JR et al. (1988) Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78: 1192-1199
41. Chang Y (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 26: 2780-2789
42. Okada RD, Glover D, Gaffney T, Williams S (1988) Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77: 491-498
43. The St Thomas's Diabetic Study Group (1986) Failure of improved glycaemic control to reverse diabetic autonomic neuropathy. Diabet Med 3: 330-334
44. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ (1990) Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 75: 635-646
45. Nilsson H, Bergström B, Lilja B, Juul-Möller S, Carlsson J, Sundkvist G (1995) Prospective study of autonomic nerve function in type 1 and type 2 diabetic patients: 24 hour heart rate variation and plasma motilin levels disturbed in parasympathetic neuropathy. Diabet Med 12: 1015-1021
46. Donaghue KC, Fung ATW, Fairchild JM, Howard NJ, Silink M (1996) Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med 13: 65-71
47. Levitt NS, Stansberry KB, Wynchank S, Vinik AI (1996) The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care 19: 751-754
48. Quadri R, Ponzani P, Zanone M et al. (1993) Changes in autonomic nervous function over a 5-year period in non-insulin-dependent diabetic patients. Diabet Med 10: 916-919
49. Mustonen J, Uusitupa M, Mäntysaari M, Länsimies E, Pyörälä K, Laakso M (1997) Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Int Med 241: 227-235
50. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS (1990) Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322: 1031-1037
51. Solders G, Tydén G, Persson A, Groth C-G (1992) Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 41: 946-951
52. Nusser J, Scheuer R, Abendroth D, Illner W-D, Land W, Landgraf R (1991) Effect of pancreatic and/or renal transplantation on diabetic autonomic neuropathy. Diabetologia 34: [Suppl 1] S 118-S120
53. Ziegler D, Dannehl K, Wiefels K, Gries FA (1992) Differential effects on near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients. Diabet Med 9: 622-629
54. Ohkubo Y, Kishikawa H, Araki E et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117
55. Reichard P, Nilsson B-Y, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309
56. Amthor K-F, Dahl-Jorgensen K, Berg TJ et al. (1994) The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 37: 579-584
57. The Diabetes Control and Complications Trial Research Group (1995) The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561-568
58. The Diabetes Control and Complications Trial Research Group (1996) The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-1298
59. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L (1991) Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 17: 1416-1423
60. Nakajo M, Shapiro B, Glowniak J, Sisson JC, Beierwaltes WH (1983) Inverse relationship between cardiac accumulation of meta-I-131 iodobenzylguanidine (I-131-MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 24: 1127-1134
61. Herman LM, Dai S, Hartman NG, McNeill JH (1994) Meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart. A marker for myocardial dysfunction? Can J Physiol Pharmacol 72: 1162-1167
62. Ganguly PK, Beamish RE, Dhalla KS, Innes IR, Dhalla NS (1987) Norepinephrine storage, distribution and release in diabetic cardiomyopathy. Am J Physiol 252: E734-E739
63. Neubauer B, Christensen NJ (1976) The noradrenaline. adrenaline and dopamine content in the cardiovascular system in long-term diabetics. Diabetes 25: 6-10
64. Mitrani RD, Klein LS, Miles WM et al. (1993) Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 22: 1344-1353
65. Wichter T, Hindricks G, Lerch H et al. (1994) Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. Circulation 89: 667-683
66. Minardo JD, Tuli MM, Mock BH et al. (1988) Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 78: 1008-1019
67. Stanton MS, Tuli MM, Radtke NL et al. (1989) Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 14: 1519-1526
68. Calkins H, Allman K, Bolling S et al. (1993) Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 88: 172-179
69. Allman KC, Stevens MJ, Wieland DM et al. (1993) Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22: 1425-1432
70. Glowniak JV (1995) Cardiac studies with metaiodobenylguanidine: a critique of methods and interpretation of results. J Nucl Med 36: 2133-2137